EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.
Christian Dejaco,Sofia Ramiro,Christina Duftner,Florent L. Besson,Thorsten A. Bley,Daniel Engelbert Blockmans,Elisabeth Brouwer,Marco A. Cimmino,Eric Clark,Bhaskar Dasgupta,Bhaskar Dasgupta,Andreas P. Diamantopoulos,Haner Direskeneli,Annamaria Iagnocco,Thorsten Klink,Lorna Neill,Cristina Ponte,Carlo Salvarani,Riemer H. J. A. Slart,Madeline Whitlock,Wolfgang A. Schmidt +20 more
TLDR
The task force recommends an early imaging test in patients with suspected LVV, with ultrasound and MRI being the first choices in GCA and TAK, respectively, which are the first EULAR recommendations providing up-to-date guidance for the role of imaging in the diagnosis and monitoring of patients with (suspected) LVV.Abstract:
To develop evidence-based recommendations for the use of imaging modalities in primary large vessel vasculitis (LVV) including giant cell arteritis (GCA) and Takayasu arteritis (TAK). European League Against Rheumatism (EULAR) standardised operating procedures were followed. A systematic literature review was conducted to retrieve data on the role of imaging modalities including ultrasound, MRI, CT and [18F]-fluorodeoxyglucose positron emission tomography (PET) in LVV. Based on evidence and expert opinion, the task force consisting of 20 physicians, healthcare professionals and patients from 10 EULAR countries developed recommendations, with consensus obtained through voting. The final level of agreement was voted anonymously. A total of 12 recommendations have been formulated. The task force recommends an early imaging test in patients with suspected LVV, with ultrasound and MRI being the first choices in GCA and TAK, respectively. CT or PET may be used alternatively. In case the diagnosis is still in question after clinical examination and imaging, additional investigations including temporal artery biopsy and/or additional imaging are required. In patients with a suspected flare, imaging might help to better assess disease activity. The frequency and choice of imaging modalities for long-term monitoring of structural damage remains an individual decision; close monitoring for aortic aneurysms should be conducted in patients at risk for this complication. All imaging should be performed by a trained specialist using appropriate operational procedures and settings. These are the first EULAR recommendations providing up-to-date guidance for the role of imaging in the diagnosis and monitoring of patients with (suspected) LVV.read more
Citations
More filters
Journal ArticleDOI
2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Bernhard Hellmich,Ana Filipa Águeda,Sara Monti,Frank Buttgereit,Hubert de Boysson,Elisabeth Brouwer,Rebecca Cassie,Maria C. Cid,Bhaskar Dasgupta,Christian Dejaco,Gulen Hatemi,Nicole Hollinger,Alfred Mahr,Susan P Mollan,Chetan Mukhtyar,Cristina Ponte,Carlo Salvarani,Rajappa Sivakumar,Xinping Tian,Gunnar Tomasson,Carl Turesson,Wofgang Schmidt,Peter M. Villiger,Richard A. Watts,Chris Young,Raashid Luqmani +25 more
TL;DR: The recommendations for the management of LVV have been updated to facilitate the translation of current scientific evidence and expert opinion into better management and improved outcome of patients in clinical practice.
Journal ArticleDOI
FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC
TL;DR: This position paper aims to set an internationally accepted standard for FDG-PET/CT(A) imaging and reporting of LVV and PMR.
Journal ArticleDOI
Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations
Christina Duftner,Christian Dejaco,Alexandre Sepriano,Louise Falzon,Wolfgang A. Schmidt,Sofia Ramiro +5 more
TL;DR: Ultrasound and MRI provide a high diagnostic value for cranial GCA, and more data on the role of imaging for diagnosis of extracranial large vessel GCA and TAK, as well as for outcome prediction and monitoring in LVV are warranted.
Journal ArticleDOI
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis
Mehrdad Maz,Sharon A. Chung,Andy Abril,Carol A. Langford,Mark Gorelik,Gordon H. Guyatt,Amy M. Archer,Doyt L. Conn,Kathy A. Full,Peter C. Grayson,Maria Ibarra,Lisa Imundo,Susan Kim,Peter A. Merkel,Rennie L. Rhee,Philip Seo,John H. Stone,Sangeeta Sule,Robert P. Sundel,Omar I. Vitobaldi,Ann Warner,Kevin Byram,Anisha B. Dua,Nedaa Husainat,Karen E. James,Mohamad A. Kalot,Yih Chang Lin,Jason M. Springer,Marat Turgunbaev,Alexandra Villa-Forte,Amy S. Turner,Reem A. Mustafa +31 more
TL;DR: In this paper, the authors provide evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis as exemplars of large vessel vasculitis.
Journal ArticleDOI
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis
Sarah L. Mackie,Sarah L. Mackie,Christian Dejaco,Simone Appenzeller,Dario Camellino,Christina Duftner,Solange Gonzalez-Chiappe,Alfred Mahr,Chetan Mukhtyar,Gary Reynolds,Alexandre Wagner Silva de Souza,Elisabeth Brouwer,Marwan Bukhari,Frank Buttgereit,Dorothy Byrne,Maria C. Cid,Marco A. Cimmino,Haner Direskeneli,Kate Gilbert,Tanaz A. Kermani,Asad Khan,Peter Lanyon,Raashid Luqmani,Christian D Mallen,Justin C Mason,Eric L. Matteson,Peter A. Merkel,Susan P Mollan,Lorna Neill,Eoin O' Sullivan,Maria Sandovici,Wolfgang A. Schmidt,Richard A. Watts,Madeline Whitlock,Elaine Yacyshyn,Steven R. Ytterberg,Bhaskar Dasgupta +36 more
TL;DR: This dissertation aims to provide a history of neuro-Ophthalmology and rheumatology in the Czech Republic over a 40-year period from 1989 to 2002, when the disease was first diagnosed.
References
More filters
Journal ArticleDOI
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny Whiting,Anne W S Rutjes,Marie Westwood,Susan Mallett,Jonathan J Deeks,Johannes B. Reitsma,Mariska M.G. Leeflang,Jonathan A C Sterne,Patrick M.M. Bossuyt +8 more
TL;DR: The QUADAS-2 tool will allow for more transparent rating of bias and applicability of primary diagnostic accuracy studies.
Journal ArticleDOI
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.
Reva C. Lawrence,David T. Felson,Charles G. Helmick,Lesley M. Arnold,Hyon K. Choi,Richard A. Deyo,Sherine E. Gabriel,Rosemarie Hirsch,Marc C. Hochberg,Gene G. Hunder,Joanne M. Jordan,Jeffrey N. Katz,Hilal Maradit Kremers,Frederick Wolfe +13 more
TL;DR: This report provides the best available prevalence estimates for the US for osteoarthritis, polymyalgia rheumatica, gout, fibromyalgia, and carpal tunnel syndrome as well as the symptoms of neck and back pain.
National Arthritis Data Work-group. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II
Reva C. Lawrence,David T. Felson,Charles G. Helmick,LM Arnold,Hyon K. Choi,Richard A. Deyo,LM Helmick Cg Arnold,Sherine E. Gabriel,Rosemarie Hirsch,Marc C. Hochberg,Gene G. Hunder,Joanne M. Jordan,Jeffrey N. Katz,Hilal Maradit Kremers,Frederick Wolfe,FC Arnett +15 more
TL;DR: In this paper, the best available estimates of the US prevalence of and number of individuals affected by osteoarthritis, polymyalgia rheumatica and giant cell arteritis, gout, fibromyalgia, and carpal tunnel syndrome, as well as the symptoms of neck and back pain are provided.
Journal ArticleDOI
Evaluation of the quality of prognosis studies in systematic reviews.
TL;DR: A review of reviews to describe methods used to assess the quality of prognosis studies and to describe how well current practices assess potential biases is to develop recommendations to guide future quality appraisal.
Related Papers (5)
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
Gene G. Hunder,Gene G. Hunder,Daniel A. Bloch,Daniel A. Bloch,Beat A. Michel,Mary Betty Stevens,Mary Betty Stevens,William P. Arend,William P. Arend,Leonard H. Calabrese,Leonard H. Calabrese,Steven M. Edworthy,Steven M. Edworthy,Anthony S. Fauci,Anthony S. Fauci,Randi Y. Leavitt,J. T. Lie,J. T. Lie,Robert W. Lightfoot,Robert W. Lightfoot,Alfonse T. Masi,Alfonse T. Masi,Dennis J. McShane,Dennis J. McShane,John A. Mills,John A. Mills,Stanley L. Wallace,Stanley L. Wallace,Nathan J. Zvaifler,Nathan J. Zvaifler +29 more
Trial of Tocilizumab in Giant-Cell Arteritis.
The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study.
Raashid Luqmani,Ellen Lee,Surjeet Singh,M Gillett,Wolfgang A. Schmidt,Mike Bradburn,Bhaskar Dasgupta,Andreas P. Diamantopoulos,Wulf Forrester-Barker,William Hamilton,Shauna Masters,Brendan McDonald,Eugene McNally,Colin T. Pease,Jennifer Piper,John F Salmon,Allan Wailoo,Konrad Wolfe,Andrew Hutchings +18 more
2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Bernhard Hellmich,Ana Filipa Águeda,Sara Monti,Frank Buttgereit,Hubert de Boysson,Elisabeth Brouwer,Rebecca Cassie,Maria C. Cid,Bhaskar Dasgupta,Christian Dejaco,Gulen Hatemi,Nicole Hollinger,Alfred Mahr,Susan P Mollan,Chetan Mukhtyar,Cristina Ponte,Carlo Salvarani,Rajappa Sivakumar,Xinping Tian,Gunnar Tomasson,Carl Turesson,Wofgang Schmidt,Peter M. Villiger,Richard A. Watts,Chris Young,Raashid Luqmani +25 more
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
John Charles Jennette,Ronald Falk,P. A. Bacon,Neil Basu,Maria C. Cid,Franco Ferrario,Luis Felipe Flores-Suárez,W. L. Gross,Loïc Guillevin,E. C. Hagen,Gary S. Hoffman,David Jayne,Cees G. M. Kallenberg,Peter Lamprecht,Carol A. Langford,Raashid Luqmani,Alfred Mahr,Eric L. Matteson,Peter A. Merkel,Peter A. Merkel,Seza Ozen,Charles D. Pusey,Niels Rasmussen,Andrew J. Rees,David G. I. Scott,Ulrich Specks,John H. Stone,Kei Takahashi,Richard A. Watts +28 more